PAR 15.1% 22.5¢ paradigm biopharmaceuticals limited..

Ann: PAR REPORTS POSTIVE TOPLINE RESULTS IN HEART FAILURE MODEL, page-39

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 572 Posts.
    lightbulb Created with Sketch. 55
    note the error bars now overlapping i.e. non significance. This is in the best portion of patients (lower pain stratum) which PAR is now focussed on. Add in the higher pain 7-8 and significance deteriorates even more. Only significance achieved shortly after final dosing and then goes back to non significance and trending back to basline. That to me doesn't scream only a 6 week treatment regime
    https://hotcopper.com.au/data/attachments/3907/3907478-d3993d32ee3b33900b29171bcdc668ed.jpg
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.